Drug pricing: Govt decides to bypass three patents

The government's move to issue compulsory licences for three more patented cancer drugs is a jolt to multinational pharmaceutical companies.The plan is to issue CLs for Trastuzumab (or Herceptin,......

India won't participate in US probe on IPR

India on Thursday made it clear it will not take part in any unilateral investigation by the US on its intellectual property rights (IPR).             India is......

US leaders to woo Indian industry amid trade spat

Amid mounting tensions between both countries, senior US leaders are arriving in New Delhi on Monday with several American business heads in an effort to woo Indian industry, even as the threat of......

India, US to enhance engagement on IPR

India and the US on Sunday agreed to enhance their engagement on intellectual property rights, a vexed issue between the two countries. Visiting US President Barack Obama and Prime Minister......